Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

LncRNAs expressed in triple negative breast cancer of Mexican patients

ABSTRACT: LncRNAs expressed in triple negative breast cancer of Mexican patients

PROVIDER: PRJNA1128072 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

LncRNAs expressed in triple negative breast cancer of Mexican patients

Project description:We provide a detailed analysis of the expression of lncRNAs in TNBC versus Luminal tumors of breast cancer patients

2024-12-20 | GSE270721 | GEO

Identification of glucose-regulated lncRNAs in triple-negative breast cancer cells

Project description:To comprehensively identify the glucose-regulated lncRNAs, we have employed ArraryStar LncRNA Microarry discovery platform to detect lncRNA expression in glucose-starved and glucose-stimulated triple-negative breast cancer cells. Differentially expressed LncRNAs with statistical significance were identified through Volcano Plot filtering between two groups.

2019-06-03 | GSE106729 | GEO

Identification of glucose-regulated lncRNAs in triple-negative breast cancer cells

Project description:Identification of glucose-regulated lncRNAs in triple-negative breast cancer cells

| PRJNA417802 | ENA

Integrated molecular portrait of triple negative breast tumors from Mexican women using archived clinical samples

Project description:Triple negative breast tumours from archived formalin fixed paraffin embeded samples of the National Cancer Institute of Mexico were analyzed for differential gene expressión.

2015-05-12 | GSE62502 | GEO

Novel long non‐coding RNA 005620 induces epirubicin resistance of triple-negative breast cancer via regulating ITGB1 expression

Project description:In this study, a total of 12 differentially expressed lncRNAs were established through lncRNA sequencing analysis. Lnc005620 is one of the novel intronic lncRNAs which is highly expressed in Epi-R MDA-MB-231. Lnc005620 is an important lncRNA that leads to the resistance of Epirubicin in triple negative breast cancer by integrin β1.

2021-03-02 | GSE152003 | GEO

Triple therapy reduced metastasis in triple-negative breast cancer.

Project description:Triple therapy reduced metastasis in triple-negative breast cancer.

| PRJNA832953 | ENA

Differentially expressed SE-lncRNAs in lung adenocarcinoma

Project description:Differentially expressed SE-lncRNAs in lung adenocarcinoma

| PRJNA805532 | ENA

Identification of lipid-binding lncRNAs in triple-negative breast cancer

Project description:To comprehensively identify RNA molecules that are naturally associated with cellular lipid components, we isolated lipid fractions and their bound RNAs from triple-negative breast cancer (TNBC) patient tissues. Fresh frozen TNBC tissues and their normal counterparts were subjected to total RNA extraction, or in parallel, to whole cell fractionation via Hydrostatic Pressure Cycling to form a lipid-containing upper phase, a denatured protein-containing lower phase, and an insoluble fraction containing DNA and RNA (PBI Inc.) The RNAs extracted from the lipid fractions were applied to LncRNA Array v3.0 (Arraystar).

2017-02-21 | GSE92414 | GEO

Triple Negative Breast tumors: SPARC Positive Tumors vs SPARC Negative Tumors

Project description:The aim of this study was evaluate the transcriptome changes in the comparison between triple negative tumors with increased SPARC expression and triple negative tumors with decreased SPARC expression according to Nagai et al., 2011 (Breast Cancer Res Treat (2011) 126:1–14) The results generated could be of particular interest to better define the prognostic impact of SPARC expression in triple negative breast tumors

2018-07-01 | GSE98931 | GEO

FOXC1 in triple negative breast cancer

Project description:FOXC1 in triple negative breast cancer

| PRJNA882754 | ENA